Loading clinical trials...
Loading clinical trials...
The aims of this study are to assess the real-world effectiveness of efgartigimod in treating chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), describe the "treatment journey" of part...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
argenx
NCT06920004 · Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, and more
NCT06747351 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT05584631 · CIDP, Immunoglobulin Deficiency, and more
NCT06538064 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT05004493 · Antibody-mediated Rejection, NMO Spectrum Disorder, and more
PPD Virtual
Wilmington, North Carolina
Jüdisches Krankenhaus Berlin
Berlin
Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH
Bochum
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions